Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes
Crossref DOI link: https://doi.org/10.1007/s13300-017-0287-y
Published Online: 2017-07-18
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Valentine, Virginia
Goldman, Jennifer
Shubrook, Jay H.
Funding for this research was provided by:
Novo Nordisk, Inc.
Text and Data Mining valid from 2017-07-18
Article History
Received: 27 April 2017
First Online: 18 July 2017